Repligen reported $329K in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agilent A:US USD 23M 4M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 299M 14M
Catalent CTLT:US USD 32M 0
Charles River Laboratories CRL:US USD 11.38M 7.67M
Danaher DHR:US USD 64M 22M
Dentsply International XRAY:US USD 14M 1000K
Exact Sciences EXAS:US USD 5.24M 724K
Fluidigm FLDM:US USD 1.05M 13K
Henry Schein HSIC:US USD 11M 2M
Illumina ILMN:US USD 6M 0
IQVIA Holdings Inc IQV:US USD 108M 14M
Mettler Toledo International MTD:US USD 14.48M 1.72M
Myriad Genetics MYGN:US USD 800K 200K
Patterson Companies PDCO:US USD 7.54M 1.98M
Peregrine Pharmaceuticals PPHM:US USD 703K 185K
Pfizer PFE:US USD 311M 18M
Repligen RGEN:US USD 329K 58K
Thermo Fisher Scientific TMO:US USD 173M 25M
Waters WAT:US USD 12.42M 1M
West Pharmaceutical Services WST:US USD 2.2M 400K